For this study, six American safflower cultivars were selected, namely CW 99 OL, S-5344, S-3125, L75, L8 and Knowles93079. Response surface methodology (RSM) was used to optimize the operating conditions, and desirability function was used as the methodology for the optimization. The independent variables were impact dehuller rotor speed (rpm), which was expressed in terms of the peripheral Pexidartinib inhibitor speed of the impeller (m/s), and grain moisture content (%, d.b.). For all the safflower cultivars, second order polynomial models were developed for both studied responses (DA and F). The results of the optimization technique revealed that the best dehulling performance could be obtained if the system is operated at a peripheral
speed of 40.5 m/s with a grain moisture content in the range 8.4-8.9% d.b. Under these conditions, the maximum values of DA would be obtained with a percentage of fines of less than 2% for selleck kinase inhibitor all the safflower cultivars, except 1.8. The processing of L8 under these operating conditions would also lead to optimal values
of DA with an industrially acceptable percentage of fines (from 1.8 to 3.1%. d.b.). The percentages of residual hull were also calculated, and they were higher than the recommended values for a proper bed porosity (10-12%) for oil extraction with solvent. These results suggest the need to evaluate other process variables in order to achieve an appropriate hull content for the oil extraction bed. (C) 2012 Elsevier B.V. All rights reserved.”
“Purpose of review This review examines the application of next-generation sequencing (NGS) technologies in the identification of the causation of nonsyndromic genetic cardiomyopathies.
Recent findings NGS sequencing of the entire genetic coding sequence (the exome) has successfully FRAX597 nmr identified five novel genes and causative variants for cardiomyopathies without
previously known cause within the last 12 months. Continual rapidly decreasing costs of NGS will shortly allow cost-effective sequencing of the entire genomes of affected individuals and their relatives to include noncoding and regulatory variant discovery and epigenetic profiling. Despite this rapid technological progress with sequencing, analysis of these large data sets remains challenging, particularly for assigning causality to novel rare variants identified in DNA samples from patients with cardiomyopathy.
Summary NGS technologies are rapidly moving to identify novel rare variants in patients with cardiomyopathy, but assigning pathogenicity to these novel variants remains challenging.”
“BACKGROUND: Rhabdomyosarcomas, particularly those of gynecologic origin, are very rare in adults. As a result, there is little literature on the optimal staging procedure and treatment modalities for this population.
CASE: A 43-year-old woman presented with a long-standing history of menorrhagia and was subsequently diagnosed with embryonal rhabdomyosarcoma of the cervix.